AGP Executive Report
Last update: 10 hours agoCancer Research: A Chongqing drugmaker has launched China’s first domestically developed BCMA/CD3 bispecific antibody, a new addition to the country’s cancer-drug pipeline. Nutrition: China has cleared a new formula for patients who need to limit protein, while Danone has opened a Shanghai research center focused on nutrition and health. Child Health: New Chinese rules to protect children’s health and safety have taken effect. Drug Development: China now hosts nearly half of the world’s new drug trials, as its biotech sector shifts from manufacturing toward pharmaceutical innovation.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.